Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study von West, Rachel, Russel, Maurice, Bodelier, Alexander, Kuijvenhoven, Johan, Bruin, Karlien, Jansen, Jeroen, Van der Meulen, Andrea, Keulen, Eric, Wolters, Leonieke, Ouwendijk, Robert, Bezemer, Geert, Koussoulas, Vassilis, Tang, Thjon, Van Dobbenburgh, Aart, Van Nistelrooy, Marianne, Minderhoud, Itta, Vandebosch, Sigrid, Lubbinge, Hans

Volltext